1

Deep Dive: Nusinersen (Spinraza) and Eteplirsen (Exondys 51) Revenue Forecast and ASO Market Expansion in NMDs, 2025–2032

News Discuss 
The global Antisense Oligonucleotides (ASOs) used in the treatment of neuromuscular disorders (NMDs) Market is experiencing profound growth, driven by breakthrough therapies that address the underlying genetic causes of debilitating diseases. ASOs are a transformative class of precision medicines designed to modulate gene expression, offering hope for conditions with historically high... https://in.linkedin.com/company/data-bridge-market-research

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story